Cargando…
Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma
BACKGROUND: Tight junctions (TJs) are mainly composed of claudins, occludin, and tight junction adhesion molecules (JAM). The invasive and metastatic phenotype of highly invasive cancer cells has been related to abnormal structure and function of TJs, and with expression of activated matrix metallop...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866569/ https://www.ncbi.nlm.nih.gov/pubmed/24245968 http://dx.doi.org/10.1186/1746-1596-8-190 |
_version_ | 1782296181664120832 |
---|---|
author | Wang, Liping Jin, Xiangshu Lin, Dongjing Liu, Zhijing Zhang, Xiaowei Lu, Yan Liu, Yuanyuan Wang, Min Yang, Minlan Li, Jiuxia Quan, Chengshi |
author_facet | Wang, Liping Jin, Xiangshu Lin, Dongjing Liu, Zhijing Zhang, Xiaowei Lu, Yan Liu, Yuanyuan Wang, Min Yang, Minlan Li, Jiuxia Quan, Chengshi |
author_sort | Wang, Liping |
collection | PubMed |
description | BACKGROUND: Tight junctions (TJs) are mainly composed of claudins, occludin, and tight junction adhesion molecules (JAM). The invasive and metastatic phenotype of highly invasive cancer cells has been related to abnormal structure and function of TJs, and with expression of activated matrix metalloproteinases (MMPs). The relevance of these mechanisms responsible for the invasion and metastasis of ovarian carcinoma is unclear. Similarly, it is not known if the expression of claudin-6, occludin and MMP2 is related with the clinical properties of these tumors. METHODS: Expression of claudin-6, occludin, and MMP2 was detected in samples of human ovarian cancer tissues by immunohistochemistry and correlated with the clinical properties of the tumors. RESULTS: The positive expression rates of claudin-6 and MMP-2 were higher in ovarian papillary serous carcinomas than n ovarian serous adenomas (P < 0.05). There were no differences in the expression of occludin (P > 0.05). The expression of claudin-6 and occludin in ovarian cancer was not correlated with patient age, pathological grade, clinical stage, and metastasis (P > 0.05). MMP-2 expression was enhanced with increased clinical stage and metastasis (P < 0.05), but was unrelated to patient age or tumor grade (P > 0.05). There were no apparent correlations between expression of claudin-6, occludin and MMP-2 in ovarian cancer tissue (P > 0.05). CONCLUSIONS: Our data suggest, for the first time, that the claudin-6 and MMP-2 are up-regulated in ovarian papillary serous carcinomas, MMP-2 expression was enhanced with increased clinical stage and metastasis. Claudin-6 and MMP-2 may play a positive role in the invasion and metastasis of ovarian cancer. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1775628454106511. |
format | Online Article Text |
id | pubmed-3866569 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38665692013-12-19 Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma Wang, Liping Jin, Xiangshu Lin, Dongjing Liu, Zhijing Zhang, Xiaowei Lu, Yan Liu, Yuanyuan Wang, Min Yang, Minlan Li, Jiuxia Quan, Chengshi Diagn Pathol Research BACKGROUND: Tight junctions (TJs) are mainly composed of claudins, occludin, and tight junction adhesion molecules (JAM). The invasive and metastatic phenotype of highly invasive cancer cells has been related to abnormal structure and function of TJs, and with expression of activated matrix metalloproteinases (MMPs). The relevance of these mechanisms responsible for the invasion and metastasis of ovarian carcinoma is unclear. Similarly, it is not known if the expression of claudin-6, occludin and MMP2 is related with the clinical properties of these tumors. METHODS: Expression of claudin-6, occludin, and MMP2 was detected in samples of human ovarian cancer tissues by immunohistochemistry and correlated with the clinical properties of the tumors. RESULTS: The positive expression rates of claudin-6 and MMP-2 were higher in ovarian papillary serous carcinomas than n ovarian serous adenomas (P < 0.05). There were no differences in the expression of occludin (P > 0.05). The expression of claudin-6 and occludin in ovarian cancer was not correlated with patient age, pathological grade, clinical stage, and metastasis (P > 0.05). MMP-2 expression was enhanced with increased clinical stage and metastasis (P < 0.05), but was unrelated to patient age or tumor grade (P > 0.05). There were no apparent correlations between expression of claudin-6, occludin and MMP-2 in ovarian cancer tissue (P > 0.05). CONCLUSIONS: Our data suggest, for the first time, that the claudin-6 and MMP-2 are up-regulated in ovarian papillary serous carcinomas, MMP-2 expression was enhanced with increased clinical stage and metastasis. Claudin-6 and MMP-2 may play a positive role in the invasion and metastasis of ovarian cancer. VIRTUAL SLIDES: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1775628454106511. BioMed Central 2013-11-19 /pmc/articles/PMC3866569/ /pubmed/24245968 http://dx.doi.org/10.1186/1746-1596-8-190 Text en Copyright © 2013 Wang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Wang, Liping Jin, Xiangshu Lin, Dongjing Liu, Zhijing Zhang, Xiaowei Lu, Yan Liu, Yuanyuan Wang, Min Yang, Minlan Li, Jiuxia Quan, Chengshi Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma |
title | Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma |
title_full | Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma |
title_fullStr | Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma |
title_full_unstemmed | Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma |
title_short | Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma |
title_sort | clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases −2 expression in ovarian carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866569/ https://www.ncbi.nlm.nih.gov/pubmed/24245968 http://dx.doi.org/10.1186/1746-1596-8-190 |
work_keys_str_mv | AT wangliping clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma AT jinxiangshu clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma AT lindongjing clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma AT liuzhijing clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma AT zhangxiaowei clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma AT luyan clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma AT liuyuanyuan clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma AT wangmin clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma AT yangminlan clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma AT lijiuxia clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma AT quanchengshi clinicopathologicsignificanceofclaudin6occludinandmatrixmetalloproteinases2expressioninovariancarcinoma |